The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Create account Sign in

Clinical research

One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry

EuroIntervention 2012;7:1181-1188. DOI: 10.4244/EIJV7I10A189

Franz-Joseph Neumann
Franz-Josef Neumann1*, MD; Petr Widimsky2, MD, DSc; Jorge A. Belardi3, MD; on behalf of the RESOLUTE International Registry investigators
1. Heart Center Bad Krozingen, Bad Krozingen, Germany; 2. Cardiocenter, Kralovske Vinohrady, Charles University, Prague, Czech Republic; 3. Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular

Aims: To provide clinical outcome data from everyday practice for the new generation Resolute zotarolimus-eluting stent (R-ZES).

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

clinical researchzotarolimus
Share on Facebook Share on Twitter Share on Linkedin

Read next article

Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)

Latest news

New Issue
TAVI dysfunction, coronary sinus narrowing, carotid interventions through the snuffbox, and more
CT image showing a case of valve thrombosis after ViV TAVI
February 20, 2020
Editorial
Will Your Heart Team EXCEL?
Darren Mylotte
February 20, 2020
JAA
This Weeks JAA's: SAFE-A study, Coronary access after TAVR-in-TAVR and much more
February 25, 2020
Trials Book
New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI
(supported by Biotronik)
February 14, 2020
Guidance Papers
Guidelines, consensus & position papers
April 9, 2019
JAA
New ahead of print: Validation of ARC-HBR criteria
Yasushi Ueki
February 18, 2020
Editorial
New Editor-in-Chief editorial: Moving forward
Davide Capodanno
February 7, 2020